Other Technologies


Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Postherpetic Neuralgia (12/09/2011) Hatchtech completes Treatment Phase of 2b Clinical Trial of New-Generation Head Lice Treatment DeOvo (31/08/2011) QRxPharma Completes NDS Submission for MoxDuo IR (25/08/2011) Spinifex Closes AU$18.25M Expanded Series B Round (23/08/2011) QRxPharma Announces A$35 Million Capital Raising to progress MoxDuo Formulations and Support Commercialisation of MoxDuo IRs (22/07/2011) QRxPharma Announces NDA Filing for MoxDuo IR (18/07/2011) $1.1m Sounds Good for Childhood Hearing Problems (12/07/2011) QRxPharma Completes Comparative Safety Study (14/06/2011) Verva Announces AUD 2M Financing and Results of Annual General Meeting (13/05/2011) TenasiTech pioneers nanotechnology for polyurethane industrial seals (06/05/2011) QRxPharma MoxDu IR Study (06/05/2011) Hatchtech commences 2b Clinical Trial of New-Generation Head Lice Treatment DeOvo (06/05/2011) Verva Announces Isis Pharmaceuticals, Inc. Adds FGFR Drug to Development Pipeline (01/02/2011) Changes to the Board at Uniseed (31/12/2010) QRxPharma Completes A$19.8 Million Capital Raising (19/11/2010) Hatchtech raises $6.3 For DeOvo head lice phase2b clinical trial (26/10/2010) QRxPharma Limited Announces A$14 Million Placement together with a Share Purchase Plan (01/10/2010) BT Imaging Closes Funding Round (Marketwire - 23/08/10) Frost & Sullivan recognises QRxPharma’s MoxDuo® IR for innovation in pain therapy (18/08/2010) QRxPharma receives positive feedback from scientific advice meetings in Europe on MOXDUO®IR development and registration (26/07/2010) Berthold Leibinger Laserpreis 2010 (08/07/2010) Uniseed’s Investment Manager Richard Marshall talks about Pepfactant’s win in the Enterprize Competition QRxPharma Successfully Completes Pivotal Phase 3 Combination rule Study for MoxDuo^(R) IR in Patients with Post Surgical Pain (ASX Release, 14 April 2010) Hatchtech Positive DeOvo Head Lice Phase II Clinical Trial Results (Media Release, 25 March 2010) Uniseed Approves Three New Investments (Uniseed News, 21 December 2009) QRxPharma Announces Completion of Strategic Alliance Deal with Liaoning Nuokang Medicines Co Ltd for the Development of Venomics Assets (ASX Release, 20 October 2009) MoxDuo ^TM IR Demonstrates Fewer Side Effects than Percocet ^(R)(ASX Release, 25 August 2009) Verva Announces License of Key FGFR Intellectual Property to Isis Pharmaceuticals, Inc. for the Treatment of Obesity and Other Diseases (Media Release, 20 August 2009) QRxPharma Initiates Comparative Phase 2 Proof-of-Concept Study for MoxDuo (TM) IV Pain Therapy (ASX Release, 23 July 2009) Climate Ready Grants for Uniseed Companies (Uniseed News, 7 July 2009) Verva Announces AUD 2m Financing and Results of Annual General Meeting (Media Release, 12 June 2009) Uniseed invests in novel inhalable drug delivery platform (Media Release, 8 May 2009) QRxPharma successfully completes comparative study for Dual-Opioid Pain Therapy (Media Release, 20 April 2009) Uniseed Investment Powers Up Clean Technology Start-Up (Media Release, 31 March 2009) $3m for promising new fibrosis drug (Media Release, 9 February 2009) Hatchtech $2.5m new funding for Phase II head lice trials (Media Release, 8 December 2008) Uniseed Investment Sells Semiconductor Technology Assets (Media release, 23 October2008) Spinifex Secures A$12m Investment to Develop Pain Drug (Media Release, 03 September 2008) Uniseed Makes Two Further Investments in University of Queensland Technologies (Media Release, 19 August 2008) FDA Accepts Streamlined Phase 3 Development Plan for QRX "Dual Opioid" Pain Therapy (Media Release, 5 August 2008) QRx Pharma Releases Additional Phase 3 Data for "Dual Opioid" Pain Therapy (Media Release, 22 May 2008) BT Imaging Raises A$3m Series A Funding (Media Release, 19 May 2008) QRx Pharma Releases Successful Phase 3 Study Results for 'Dual Opioid' Pain Therapy (Media Release, 5 May 2008) Chairman Recognised on the Queen's Birthday Honours List (Media Release, 11 June 2007) Active Torque Receives Smart State Start-up Grant (Media Release, 22 February 2007) Uniseed Appoints New CEO (Media Release, 28 November 2006) Investors Back Engine Tuning Technology (Media Release, 1 September 2006) $1.67m Grant to Develop Pain Drug (Media Release, 3 August 2006)